Medicare’s GLP-1 Bridge Program: What It Is, Who Qualifies, and How to Get Coverage

For years, many Medicare beneficiaries have been unable to access GLP-1 medications for weight loss because Medicare generally did not cover these drugs when prescribed solely for obesity. That changed on July 1, 2026, when the Centers for Medicare & Medicaid Services (CMS) launched the Medicare GLP-1 Bridge Program.

This temporary demonstration program gives eligible Medicare beneficiaries access to certain GLP-1 medications for a $50 monthly copayment through December 31, 2027.

If you’ve been wondering whether you qualify, here’s what you need to know.

What Is the Medicare GLP-1 Bridge Program?

The Medicare GLP-1 Bridge is a temporary CMS program designed to expand access to certain GLP-1 medications for eligible Medicare beneficiaries who meet specific medical criteria. Unlike traditional Medicare Part D coverage, this program operates outside of your prescription drug plan, allowing qualifying individuals to receive covered medications at a flat monthly cost.

Currently covered medications include:

  • Wegovy® (injection or tablet)
  • Zepbound® KwikPen
  • Foundayo® tablets

Who Qualifies?

To be eligible, you must:

  • Be enrolled in Medicare Part D or a Medicare Advantage plan that includes prescription drug coverage.
  • Meet the program’s medical eligibility requirements.
  • Receive a prescription from your healthcare provider.
  • Have your provider complete and submit the required prior authorization.
  • Participate in a lifestyle program that includes healthy eating and physical activity, as certified by your provider.

In addition, you must meet one of the following medical criteria:

  • BMI of 35 or higher, or
  • BMI of 30 or higher with heart failure, uncontrolled high blood pressure, or chronic kidney disease, or
  • BMI of 27 or higher with prediabetes, a previous heart attack or stroke, or symptomatic peripheral artery disease.

Who Does NOT Qualify?

Some Medicare beneficiaries may already qualify for GLP-1 medications through their regular Medicare Part D coverage rather than the Bridge Program.

Generally, the Bridge Program is not intended for people using GLP-1 medications to treat conditions such as:

  • Type 2 diabetes
  • Certain cardiovascular conditions already covered by Medicare
  • Moderate to severe obstructive sleep apnea
  • MASH (metabolic dysfunction-associated steatohepatitis)

If you have one of these diagnoses, your medication should typically be processed through your Medicare Part D plan instead of the Bridge Program.

How Much Does It Cost?

Eligible beneficiaries pay a $50 monthly copayment.

It’s important to understand that because the GLP-1 Bridge operates outside the Medicare Part D benefit:

  • The $50 payment does not count toward your Part D deductible.
  • It does not count toward your annual out-of-pocket maximum (TrOOP).
  • The Extra Help (Low-Income Subsidy) program does not reduce the $50 copayment.

How Do You Get the Medicare GLP-1 Bridge?

If you think you may qualify, follow these steps:

1. Talk with your healthcare provider. Discuss whether a GLP-1 medication is appropriate for your health needs.

2. Confirm your eligibility. Your provider will determine whether you meet the BMI and medical requirements.

3. Have your provider submit the paperwork. Your provider must send a prescription and complete the required prior authorization.

4. Fill your prescription. Once approved, you’ll receive information confirming your coverage through the Medicare GLP-1 Bridge Program.

Should You Speak with Your Medicare Agent?

Absolutely. While the GLP-1 Bridge Program is separate from your Medicare Part D plan, it’s still important to review your prescription drug coverage each year. Medicare plans change annually, and your medication needs may change over time. Working with a licensed Medicare agent can help ensure you’re enrolled in a plan that fits your healthcare needs and budget. We’re here to help you understand your Medicare options and answer your questions about prescription drug coverage. If you’re unsure how the GLP-1 Bridge Program fits into your Medicare coverage, contact our office today for personalized guidance.